early success:
DR. Albert Sabin, Unpublished Study sent to Bob .
Bob's friend in Japan, another clinical study:
Bob's clinical study auto immune disease, MS, others.
E-Contact
Bob
or call 417 300 3056
Treatment of multiple sclerosis with anti-measles cow
colostrum.
Previous virological and immunological studies have suggested that multiple
sclerosis (MS) is
an auto-immune disease triggered by a virus infection. In order to inhibit
the growth of
measles virus in the patient's jejunum, we obtained an IgA-rich cow
colostrum containing
anti-measles lactoglobulin resistant to proteases. This colostrum was orally
administered to
patients with MS to investigate its effect on the course of the disease.
Measles-positive
antibody colostrum was orally administered every morning to 1 S patients
with MS at a daily
dosage of 100 ml for 30 days. Similarly, measles-negative antibody (less
than 8) control
colostrum was orally administered to S patients. As a clinical assessment,
disability scores
developed by the International Federation of Multiple Sclerosis Societies
were used. As a
result, of 7 hiBh NT titre (S 12-5120) anti-measles colostrum recipients S
patients improved
and 2 remained unchanged... Among 8 low NT titre (8-32) anti-measles
colostrum recipients
5 patients improved and 3 remained unchanged. However, of S negative NT
titre (less than
8) colostrum recipients 2 patients remained unchanged and 3 worsened. No
side-effects
were observed in colostrum recipients. These findings suggest the efficacy
of orally
administered anti-measles colostrum in improving the condition of MS
patients (P less than
0.05).
Macular degeneration
